The study discusses the problem of role of various substances in the mechanisms of contraction and relaxation of human term pregnant myometrium in the experimental in vitro conditions.
INTRODUCTION
Myometrium is characterized by the presence of various receptors and ion channels that activity can be pharmacologically modulated. The majority of receptor-controlled physiological processes are regulated by ion channels. The role of ion channels in influencing uterine activity is important not only for contraction but relaxation, too. Potassium ion channels are the largest family of ion channels and are widely represented in smooth muscle including myometrium (1, 2, 3) and are involved in mediating smooth muscle relaxation (2, 4, 5) . The ligand-sensitive potassium large conductance calcium-activated ion channel (BK Ca2+ ) is activated by membrane depolarization and also by an increase in the intracellular calcium concentration, thereby playing a pivotal role in the modulation of uterine contractility and myometrial calcium homeostasis (6) . The opening of ATP-sensitive potassium ion channels (K ATP ) results in an outward flow of K + ions, drawing the cell membrane potential closer to the K + equilibrium potential, and thereby reducing cellular excitability and contractility (6) .
Phosphodiesterases (PDE) are the family of enzymes that catalyze the hydrolysis of 3 cyclic phosphate bonds cAMP and/or cGMP and based on their organ distribution they affect different functions. Each cell type can produce several different subtypes of PDE and myometrial cells are no exception. One of the mechanisms responsible for the relaxation of the myometrial smooth muscle is the elevation of cyclic adenosine monophosphate (cAMP) and partly cyclic guanosine monophosphate (cGMP) (7). To date, there is an interest in the substances known as the PDE inhibitors that can have an important role in the process of relaxation of myometrium (7, 8) .
Tachykinin peptides are one of the largest family of neuropeptides whose biological effects are mediated via selective NK 1 , NK 2 and NK 3 neurokinin receptors, respectively for substance P (SP), neurokinin A (NKA) and neurokinin B (NKB) (9, 10) . All tachykinin receptors are members of the 7-transmembrane-G-protein-coupled family receptors and induce the activation of phospholipase C, producing inositol triphosphate (11, 12) . Distribution and agonist-mediated uterotonic effect of all three neurokinin receptors in human uterus has been reported (13, 14, 15) .
The aim of the study was to assess mechanisms of contraction and relaxation of human term pregnant myometrium in the experimental in vitro conditions using potassium ion channels openers (pinacidil and NS1619) and potassium ion channels closers (glibenclamide and tetraethylammonium), phosphodiesterase inhibitors (rolipram and sildenaphil) as well as tachykinins (neurokinin A, neurokinin B and substance P).
METHODS
Human myometrium tissue samples were collected from term pregnant women who had to undergo Caesarean section. The sample of myometrium tissue was excised at the Clinic of Obstetrics and Gynecology of Jessenius Medical Faculty, using a scalpel, from the uterine incision made at Caesarean section in the lower uterine segment and placed in KrebsHenseleit buffer. This buffer containig (μM): NaCl, 110.0; KCl, 4.8; CaCl 2 , 2.35; MgSO 4 , 1.20; KHPO 4 , 1.20; NaHCO 3 , 25.0; in distilled water, maintains the survival of the sample. After the excision, the sample from each woman was immediately processed into myometrial strip of approximate size of 7x2mm at the Department of Pharmacology of Jessenius Medical Faculty. The time from sample excision to make the strip was only a few minutes.
Then human myometrial strips were given into an organ bath with Krebs-Henseleit buffer. Organ chambers were maintained at 36.5 ± 0.5ºC and were aerated continuously with the mixture 95 % O 2 and 5 % CO 2 , to maintain pH = 7.5 ± 0.1.
The contractile activity of human term pregnant myometrial strips were induced by the oxytocin administration into organ bath. The mean peak amplitude of contraction of the myometrial strips to the doses of oxytocin with subsequent administration of potassium ion channels openers (pinacidil and NS1619), potassium ion channels closers (glibenclamide and tetraethylammonium), phosphodiesterase inhibitors (rolipram and sildenaphil) and tachykinins (neurokinin A, neurokinin B and substance P) were measured as a parameter of human term pregnant myometrial reactivity in in vitro conditions.
Contractile activity was measured isometrically using force tranducer (TSR 10G, Vývoj Martin, Slovakia), amplifier (M 1101 SUPR, Mikrotechna Praha, Czech Republic Patient recruitment was carried out by provision of information sheets and by obtaining written informed consent. All procedures were carried out according to EU directives and reviewed by Ethical Committee of the Comenius University.
Statistical analysis was performed using t-test and one-way variance analysis (ANOVA). M A R T I N I A N A 2 0 1 2 S U P P L . 1
RESULTS
Specific agonist-opener of K ATP potassium ion channels -pinacidil significantly reduced contractile activity (p<0.05) of human term pregnant myometrial strips induced by administration of oxytocin in in vitro conditions (Fig. 1A) . Pinacidil showed the decrease in contractile amplitude of oxytocin-induced contraction to 30.23 %. This tocolytic effect of pinacidil was confirmed by the application of its specific antagonist-closer of K ATP potassium ion channels -glibenclamide that significantly increased the contractile activity (p<0.05) of human term pregnant myometrial strips by 72 % in in vitro conditions (Fig. 1A) . In contrast, specific agonist-opener of BK Ca2+ potassium ion channels -NS1619 decreased contractile activity in human term pregnant myometrial strips induced by oxytocin in in vitro conditions, but not significantly (Fig. 1B) . NS1619 showed the decrease in contractile amplitude of oxytocin-induced contraction to 76.8 %. Similarly, its specific antagonist-closer of BK Ca2+ potassium ion channels -tetraethylammonium increased the contractile activity of human term pregnant myometrial strips by 29.2 % in in vitro conditions, but its effect was not significant (Fig. 1B) . Phosphodiesterase-4 inhibitor -rolipram and phosphodiesterase-5 inhibitor -sildenaphil led to statistically significant decrease of oxytocin-induced contractile activity (p<0.05) in human term pregnant myometrial strips in in vitro conditions ( Fig. 2A, 2B ). Therapy with rolipram showed the decrease in contractile amplitude of oxytocin-induced contraction to 47.98 % and with sildenaphil to 37.9 %. Tachykinins -neurokinin A, neurokinin B and substance P markedly stimulated the activity of the human term pregnant myometrial strips (Fig, 3A, 3B, 4A ). In neurokinin A the change of amplitude exceeded the spontaneous activity of the term pregnant myometrial strips by 43.1 %, in neurokinin B by 38.1 % and in substance P by 39.7 %. The contractile activity of oxytocin was 36.1 %. Tachykinins in in vitro conditions had a very similar effect on myometrial contractility which can be compared to stimulating effect, in practice approved and used oxytocin. (Fig. 4B) . 
DISCUSSION
The results of our experimental study showed the different effectiveness of potassium ion channels openers and potassium ion channels closers, phosphodiesterase inhibitors as well as tachykinins in mechanisms of contraction and relaxation of human term pregnant myometrium in in vitro conditions.
The effects of BK Ca2+ and K ATP potassium ion channels in myometrium are probably dependent on many various factors or conditions. There are differences between experimental studies in animals (16, 17, 18) and clinical studies in humans (19, 20) . In human myometrium the presence of these channels depend on functional state of myometrium that means non pregnant, mid pregnant, term pregnant not in labour, term pregnant in labour or late pregnant myometrium. In our experiment all samples of the human myometrium tissue were obtained from term pregnant women. We have found that the activity of K ATP potassium ion channels in human term pregnant myometrial strips was high, which resulted in a significant decrease of contractile activity of myometrial strips in in vitro conditions. In contrast, the activity of BK Ca2+ potassium ion channels in the contractility of human term pregnant myometrial strips was reduced and did not lead to significant decrease of contractile activity of myometrial strips in in vitro conditions. The results of our experiment showed a different participation of BK Ca2+ and K ATP potassium ion channels in the contractility of human term pregnant myometrium in in vitro conditions (21) . BK Ca2+ potassium ion channels probably have a more important function to induce contractions of human term pregnant myometrium in labour.
Phosphodiesterase-4 inhibitor -rolipram and phosphodiesterase-5 inhibitor -sildenaphil led to statistically significant decrease of oxytocin-induced contractile activity in human term pregnant myometrial strips in in vitro conditions. The tocolytic effects of inhibitors of phosphodiesterases were the result of the increase of intracellular cyclic nucleotides, in the case of rolipram cAMP and cGMP in sildenaphil. Some experimental studies show that PDE inhibitors could represent a possible future therapeutic potential in the process of myometrial contractility modulation (8, 22, 23) .
It is known that tachykinins stimulate activity of phospholipase C via G-protein that connects mainly to Ca 2+ influx through VOCs (voltage-operated channels) channels (24) , in the same manner as oxytocin causes the stimulatory respond by binding to its receptor (25) . In our study, all three tachykinins had shown to be more potent stimulators of contractility of human term pregnant myometrial strips than oxytocin which also indicates their probable role in the initiation of parturition. In conclusion, the results indicate that tachykinins produce their stimulatory effects probably via mutual nonspecific co-operation of tachikinins receptors NK 1 , NK 2 and NK 3 . The mechanisms that influence the membrane potential and excitability of myometrial smooth muscle cell are not still clear. There are many experimental studies that discuss this issue in order to find "ideal" substance that could be effective in the management of labour and does not have a negative impact on the organism both mother and fetus.
We discuss the effects of various substances that participate in the mechanisms of contraction and relaxation in human term pregnant myometrium in in vitro conditions. This experimental study is only the beginning of our research. In the next experiments we would like to use other substances eventually combination of substances and discuss this problem more detailed.
